GSK plc (GSK)
NYSE: GSK · IEX Real-Time Price · USD
38.21
-0.17 (-0.44%)
At close: Jul 2, 2024, 4:00 PM
38.35
+0.14 (0.37%)
After-hours: Jul 2, 2024, 7:43 PM EDT
GSK Analyst Ratings
Total Analysts
4
Consensus Rating
Buy
Price Target
$48.00
Upside
+25.62%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Jefferies | Jefferies | Strong Buy Maintains $53 → $53 | Strong Buy | Maintains | $53 → $53 | +38.71% | Jul 2, 2024 |
| Goldman Sachs | Goldman Sachs | Hold Initiates $47 | Hold | Initiates | $47 | +23.00% | May 30, 2024 |
| Guggenheim | Guggenheim | Hold → Strong Buy Upgrades n/a | Hold → Strong Buy | Upgrades | n/a | n/a | Mar 4, 2024 |
| Morgan Stanley | Morgan Stanley | Hold Initiates $44 | Hold | Initiates | $44 | +15.15% | Jan 23, 2024 |
| Jefferies | Jefferies | Hold → Strong Buy Upgrades $39 → $48 | Hold → Strong Buy | Upgrades | $39 → $48 | +25.62% | Jan 3, 2024 |
| DZ Bank | DZ Bank | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Feb 11, 2022 |
| Barclays | Barclays | Sell → Hold Upgrades n/a | Sell → Hold | Upgrades | n/a | n/a | Nov 5, 2021 |
| SVB Leerink | SVB Leerink | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Mar 23, 2021 |
| Deutsche Bank | Deutsche Bank | Hold → Strong Sell Downgrades n/a | Hold → Strong Sell | Downgrades | n/a | n/a | Feb 4, 2021 |
| Deutsche Bank | Deutsche Bank | Hold Initiates n/a | Hold | Initiates | n/a | n/a | Jan 15, 2021 |
| Argus Research | Argus Research | Strong Buy Maintains n/a | Strong Buy | Maintains | n/a | n/a | Aug 20, 2018 |
| Citigroup | Citigroup | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Jul 5, 2017 |